APA (7th ed.) Citation

N, W., M, Z., V, H., MJ, S., D, C., EV, S., . . . CL, W. (2025). Dual-energy CT iodine concentration as a biomarker for immunotherapy treatment response in metastatic melanoma and renal cell carcinoma patients. European radiology, 35(8), 4417. https://doi.org/10.1007/s00330-025-11351-4

Chicago Style (17th ed.) Citation

N, Wiley, Zecevic M, Ho V, Stolzberg MJ, Cox D, Soloff EV, Hall E, and Wang CL. "Dual-energy CT Iodine Concentration as a Biomarker for Immunotherapy Treatment Response in Metastatic Melanoma and Renal Cell Carcinoma Patients." European Radiology 35, no. 8 (2025): 4417. https://doi.org/10.1007/s00330-025-11351-4.

MLA (9th ed.) Citation

N, Wiley, et al. "Dual-energy CT Iodine Concentration as a Biomarker for Immunotherapy Treatment Response in Metastatic Melanoma and Renal Cell Carcinoma Patients." European Radiology, vol. 35, no. 8, 2025, p. 4417, https://doi.org/10.1007/s00330-025-11351-4.